Maternal SARS-CoV-2 sero-surveillance using newborn dried blood spot (DBS) screening specimens highlights extent of low vaccine uptake in pregnant women. Issue 5 (30th November 2022)
- Record Type:
- Journal Article
- Title:
- Maternal SARS-CoV-2 sero-surveillance using newborn dried blood spot (DBS) screening specimens highlights extent of low vaccine uptake in pregnant women. Issue 5 (30th November 2022)
- Main Title:
- Maternal SARS-CoV-2 sero-surveillance using newborn dried blood spot (DBS) screening specimens highlights extent of low vaccine uptake in pregnant women
- Authors:
- Moat, Stuart J.
Hillier, Sharon
de Souza, Sikha
Perry, Malorie
Cottrell, Simon
Lench, Alex
Payne, Heather
Jolles, Stephen - Abstract:
- ABSTRACT: SARS-CoV-2 vaccine uptake in pregnant women is believed to be low and lags behind the general population contributing to increased hospital admissions, and poor maternal and fetal outcomes. However, there is a paucity of information on the SARS-CoV-2 serostatus of pregnant women to help inform policy planning and assess impact of interventions to improve vaccine uptake in this at-risk group. We analyzed 8, 683 residual, anonymized newborn screening dried bloodspot (DBS) specimens during a 15-month period (October 2020 to December 2021) in Wales (UK) for SARS-CoV-2 IgG-antibodies. We compared newborn DBS antibody-positive rates to the percentage number of pregnant women vaccinated and the percentage number of antibody-positive adults. In December 2021, 47.8% of women in Wales had received two doses of the vaccine by their delivery date; however, only 41.1% of DBS specimens had high antibody concentrations. Results indicate that a proportion of pregnant women remain at higher-risk of COVID complications, particularly given the reduction in antibody neutralization of Omicron versus the Delta variant. Our study demonstrates the utility of newborn screening DBS specimens to monitor SARS-CoV-2 serostatus in pregnant women representing maternal vaccination and natural infection in almost real-time, defining the immunity gap and impact of any interventions.
- Is Part Of:
- Human vaccines & immunotherapeutics. Volume 18:Issue 5(2022)
- Journal:
- Human vaccines & immunotherapeutics
- Issue:
- Volume 18:Issue 5(2022)
- Issue Display:
- Volume 18, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 18
- Issue:
- 5
- Issue Sort Value:
- 2022-0018-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-11-30
- Subjects:
- COVID-19 -- newborn screening -- dried blood spots -- SARS-CoV-2 IgG antibodies -- vaccination -- serostatus
Vaccines -- Periodicals
615.372 - Journal URLs:
- http://www.tandfonline.com/toc/khvi20/current ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/21645515.2022.2089498 ↗
- Languages:
- English
- ISSNs:
- 2164-5515
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4336.468655
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24192.xml